Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland Study design and 1-year interim report on the feasibility of the lifestyle intervention programme

[1]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[2]  A. Sasaki,et al.  [Prevention of diabetes mellitus]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[3]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[4]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[5]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[6]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[7]  R N Bergman,et al.  Mapping Genes for NIDDM: Design of the Finland—United States Investigation of NIDDM Genetics (FUSION) Study , 1998, Diabetes Care.

[8]  A. Amos,et al.  The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[9]  W. Knowler,et al.  Glucose tolerance and mortality, including a substudy of tolbutamide treatment , 1997, Diabetologia.

[10]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[11]  K. Alberti.  The Clinical Implications of Impaired Glucose Tolerance , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[12]  M. Uusitupa.  Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance. , 1996, Annals of medicine.

[13]  L. Valsta,et al.  The compilation of food analysis values as a database for dietary studies—the finnish experience , 1996 .

[14]  M. Uusitupa,et al.  The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. , 1996, European journal of clinical nutrition.

[15]  M. Laakso,et al.  Structure and Costs of Health Care of Diabetic Patients in Finland , 1996, Diabetes Care.

[16]  K. Narayan,et al.  Preventing Non-Insulin-Dependent Diabetes , 1995, Diabetes.

[17]  D. Bourn,et al.  Impaired Glucose Tolerance and NIDDM: Does a Lifestyle Intervention Program Have an Effect? , 1994, Diabetes Care.

[18]  D N Mendelson,et al.  Health care expenditures for people with diabetes mellitus, 1992. , 1994, The Journal of clinical endocrinology and metabolism.

[19]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.

[20]  M. Uusitupa,et al.  Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus. , 1993, Journal of the American Dietetic Association.

[21]  J. Levy,et al.  'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance. , 1993, The Quarterly journal of medicine.

[22]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[23]  F. Pi‐Sunyer,et al.  Medical Hazards of Obesity , 1993, Annals of Internal Medicine.

[24]  R. Hamman.  Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). , 1992, Diabetes/metabolism reviews.

[25]  R. Turner,et al.  Can Life‐styles of Subjects With Impaired Glucose Tolerance Be Changed? A Feasibility Study , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[26]  P Oja,et al.  Validity of a two kilometre walking test for estimating maximal aerobic power in overweight adults. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[27]  Veikko Salomaa,et al.  Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. , 1991, International journal of epidemiology.

[28]  R. Laukkanen,et al.  A 2-km Walking Test for Assessing the Cardiorespiratory Fitness of Healthy Adults , 1991, International journal of sports medicine.

[29]  J. Manson,et al.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. , 1991, Archives of internal medicine.

[30]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[31]  J. Assal,et al.  [Long-term complications in diabetes mellitus]. , 1989, Acta medica portuguesa.

[32]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[33]  M. Harris.  Impaired Glucose Tolerance in the U. S. Population , 1989, Diabetes Care.

[34]  J. Palmgren,et al.  Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. , 1988, American journal of epidemiology.

[35]  P. Zimmet.  Primary Prevention of Diabetes Mellitus , 1988, Diabetes Care.

[36]  H. Keen,et al.  The Whitehall Study: Ten Year Follow‐up Report on Men With Impaired Glucose Tolerance With Reference to Worsening to Diabetes and Predictors of Death , 1984, Diabetic medicine : a journal of the British Diabetic Association.

[37]  R J Jarrett,et al.  Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. , 1983, British medical journal.

[38]  K. Ratzmann,et al.  The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance. , 1983, Diabete & metabolisme.

[39]  G. Sartor,et al.  Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation , 1980, Diabetes.

[40]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[41]  J. Paasikivi.  Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes. , 1970, Acta medica Scandinavica. Supplementum.

[42]  S. Fajans,et al.  Tolbutamide-induced Improvement in Carbohydrate Tolerance of Young People with Mild Diabetes Mellitus , 1960, Diabetes.

[43]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.

[44]  R. Fitz.  The Prevention of Diabetes Mellitus , 1940 .

[45]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .